## COO: The Cooper Companies, Inc. - XLV: Healthcare

### Executive Summary

No thesis match: MRS_20 1.7% below STRENGTH zone (4.0-10.0%); PEG 2.15 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: declining volume (33% of avg), momentum weakening (-2.4% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($78.56)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 5, Bearish: 0)

**1. CooperCompanies Appoints Walter M Rosebrough, Jr. to its Board of Directors**
- Source: InvisionMag.com | 20251226T150755 | Bullish | Relevance: 100%
- CooperCompanies has appointed Walter M. Rosebrough, Jr. to its Board of Directors, a move effective January 3, 2026, and part of a cooperation agreement with Browning West. Rosebrough, former CEO of STERIS plc, brings extensive medical device industry experience and will join the Corporate Governance & Nominating Committee, with serious consideration to become Board Chair by the end of 2026. The company also committed to appointing another independent director with mutual agreement from Browning West.

**2. Assenagon Asset Management S.A. Reduces Stock Position in The Cooper Companies, Inc. $COO**
- Source: MarketBeat | 20251226T091150 | Neutral | Relevance: 100%
- Assenagon Asset Management S.A. significantly reduced its stake in The Cooper Companies, Inc. by 97.5% in the third quarter, selling 234,339 shares and retaining 6,107 shares valued at $419,000. Despite this reduction by one firm, other institutional investors have adjusted their holdings, and Cooper Companies reported strong quarterly earnings, authorized a $2.0 billion share repurchase program, and saw insider buying, signaling potential confidence amidst some activist engagement. The company's future outlook includes optimistic EPS guidance for FY2026 and Q1 2026, with an average analyst rating of "Moderate Buy."

**3. Albert White Bought 4.4% More Shares In Cooper Companies**
- Source: Simply Wall Street | 20251224T110826 | Bullish | Relevance: 100%
- Albert White, President of The Cooper Companies (NASDAQ:COO), recently purchased US$808k worth of shares, increasing his holding by 4.4%. This significant insider buy, valued at an average price of US$80.80 per share, suggests strong confidence in the company's future prospects. Insiders at Cooper Companies have been buying shares over the last year without selling, indicating a general trend of optimism.

**4. Thompson Investment Management Inc. Buys Shares of 54,370 The Cooper Companies, Inc. $COO**
- Source: MarketBeat | 20251228T130741 | Bullish | Relevance: 100%
- Thompson Investment Management Inc. revealed it purchased 54,370 shares of The Cooper Companies, Inc. (NASDAQ:COO) in the third quarter, valued at approximately $3.73 million. This comes amidst positive sentiment from analysts and insider buying from the company's CEO and another insider, signaling confidence. Cooper Companies also announced a $2.0 billion share repurchase program, further highlighting leadership's belief in the company's value.

**5. The Cooper Companies, Inc. $COO Shares Sold by Swedbank AB**
- Source: MarketBeat | 20251225T111952 | Somewhat-Bullish | Relevance: 100%
- Swedbank AB significantly reduced its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 24%, selling 284,744 shares, though it still holds 0.45% of the company. Despite this sale, Cooper Companies recently surpassed quarterly earnings estimates, provided strong FY2026 guidance, and authorized a $2.0 billion stock buyback. The company also saw mixed governance signals, including a new board appointment and insider share purchases, alongside a cooperation agreement with activist investor Browning West.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 10, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | Citigroup | $88 | $72 | +22% |
| 2025-12-08 | Morgan Stanley | $83 | $76 | +9% |
| 2025-12-08 | Goldman Sachs | $71 | $64 | +11% |
| 2025-12-05 | Stifel | $95 | $85 | +12% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | Citigroup | main | Neutral |
| 2025-12-08 | Morgan Stanley | main | Equal-Weight |
| 2025-12-08 | Goldman Sachs | main | Sell |
| 2025-12-05 | Stifel | reit | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 7 ($0.91M) |
| Sells | 1 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 12.2% (-1.1%)
- Blackrock Inc.: 7.8% (-0.8%)
- Capital World Invest: 5.4% (+25.7%)
- T. Rowe Price Invest: 5.0% (+33.2%)
- State Street Corpora: 4.4% (-0.9%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-2.4% 5d) with bearish MACD, trend may be turning.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 10 raises (avg +14%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.15 elevated, pricing in significant growth expectations. Analyst sentiment positive (10 raises, avg +14%). Insider buying signal ($0.9M), management confidence. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $16.4B |
| Beta | 1.05 |
| 52W Range | $61.78 - $100.24 |
| Short Interest | 3.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.15 |
| Forward P/E | 16.7 |
| Current P/E | 18.3 |
| YoY Growth | 9.7% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 4.1% to 1.7% (-2.4% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 2.3pp (needs >4.0% for momentum thesis). MRS_5 (-0.8%) diverging from MRS_20 - short-term weakness emerging. Full SMA alignment bullish (above 20/50/200 SMAs). Volume at 33% of 20MA suggests lack of conviction. OFD pattern: -DLL (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 1.72% (CS: 74) | Neutral |
| RSI_14 | 63.9 | Neutral |
| MACD Histogram | -0.07 | Bearish |
| vs SMA20 | 1.027x | Above |
| vs SMA50 | 1.093x | Above |
| vs SMA200 | 1.110x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $82.62
- **Stop Loss:** $78.56 (4.9% risk)
- **Target:** $86.68 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 325
- **Position Value:** $26,851.50
- **Portfolio %:** 26.85%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.10x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with selective risk appetite amid holiday trading. VIX at extreme lows (13.6) signals complacency while positive yield curve (+59bps) and stable economic data support continuation. Focus on quality names with AI/infrastructure exposure while monitoring January volatility reset.*

### Earnings

**Next:** 2026-03-05 (Est: $1.03)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $1.11 | $1.15 | +3.3% |
| 2025Q3 | $1.07 | $1.10 | +3.0% |
| 2025Q2 | $0.93 | $0.96 | +3.3% |
| 2025Q1 | $0.91 | $0.92 | +0.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*